$3.180
-0.039 (-1.24%)收盤時
MYGN 資訊
MYGN 事件
Major U.S. Indices Drop Sharply Amid U.S.-Iran Tensions
The major averages closed sharply lower to kick off September amid increasing tensions between the U.S. and Iran. Inflation concerns and surging oil prices lifted bond yields in the U.S. and elsewhere as worries continue to mount over whether the Federal Reserve will tighten monetary policy later this month.U.S. Central Command announced that U.S. forces began striking Islamic Revolutionary Guard Corps targets in Iran. President Trump said the attacks came in retaliation for Iran attempting to place more sea mines in the Strait of Hormuz. The move marks the second set of U.S. airstrikes on Iran in three days. Oil prices, which had already been trending higher given the elevated tensions, surged over 5% after the news.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Medtronicreported, narrowed its FY27 earnings guide, and announced a $700M investment in Cornerstone RoboticsFervo Energyannounced awith GoogleJohn Ternus has officiallyof Apple, taking the reigns from Tim Cook, who will remain as executive chairAnthropic has entered into a $35B cloud compute deal with Nvidia-backedLambda,Meanwhile, Anthropic introduced2. WALL STREET CALLS:Robinhoodto Overweight at Morgan Stanley on improved growth outlookMyriad Geneticsto Underweight from Overweight at Piper SandlerEvercoreDuolingoto Outperform on product improvementsBofAEdison Internationaland PG&Eto Neutral with California wildfire reform delayedRosenblattUberat Buy, Lyftat Neutral3. AROUND THE WEB:Teslareported mixed sales results in August across Europe, Reuters saysS&P Globalis considering spinning out Capital IQ Pro, Bloomberg reportsNovartishas paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after three patients died, Reuters reportsChevronis finalizing a deal for the operating rights to two oilfields in Venezuela's Orinoco Belt that hold billions of barrels of heavy oil reserves, Bloomberg saysStellantisis halting production at its Mirafiori plant in Turin due to shortages of engine components following stronger-than-expected demand for hybrid vehicles, Reuters reports4. MOVERS:Comstock Resourcesgained afterwith the State Oil Company of the Azerbaijan Republic and a $450M joint venture with Jerry JonesCapricor Therapeuticsincreased after Piper Sandlerthe stock to OverweightKohl'sslid after naming Ryan Waymire asAlumiswas lower after reporting its LUMUS trialand secondary endpointsEos Energyfell after filing to5. EARNINGS/GUIDANCE:Nioand provided guidance for Q3MiniMed, with EPS missing consensusYext, with EPS higher year-over-yearRegis, with CEO Susan Lintonsmith commenting on "a year of continued progress toward strengthening the foundation of our business"Broadcomtoon September 2INDEXES:The Dow fell 419.02, or 0.79%, to 52,766.88, the Nasdaq lost 271.12, or 1.03%, to 26,099.77, and the S&P 500 declined 54.67, or 0.71%, to 7,631.47.
Major U.S. Averages Decline Amid Inflation Concerns
The major averages were broadly lower to start the month of September as inflation concerns and rising oil prices lifted bond yields in the U.S. and elsewhere. Worries continue to mount over whether the Federal Reserve will tighten monetary policy later this month.In other economic data news, the ISM Manufacturing PMI fell to 54.6 in August from July's near four-year high of 55.6, below market expectations of 55.2. The news comes as the JOLTS report said that job openings in the U.S. increased by 89,000 to 7.271M in July from a downwardly revised 7.182M in June. The openings figure came in below market expectations.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Medtronicreported, narrowed its FY27 earnings guide, and announced a $700M investment in Cornerstone RoboticsFervo Energyannounced awith GoogleJohn Ternus has officiallyof Apple, taking the reigns from Tim Cook, who will remain as executive chairAnthropic has entered into a $35B cloud compute deal with Nvidia-backedLambda,SpaceXis shaking up its data center team after facility issues,2. WALL STREET CALLS:Robinhoodto Overweight at Morgan Stanley on improved growth outlookMyriad Geneticsto Underweight from Overweight at Piper SandlerEvercoreDuolingoto Outperform on product improvementsBofAEdison Internationaland PG&Eto Neutral with California wildfire reform delayedRosenblattUberat Buy, Lyftat Neutral3. AROUND THE WEB:Novartishas paused eight clinical trials of rap-cel, an experimental cell therapy targeting autoimmune and neurological disorders, after three patients died, Reuters reportsMagna Internationalis investing an additional $35M in Yuma Energy, a Bengaluru-based firm that operates a battery-swapping network for electric two- and three-wheelers, TechCrunch reportsChevronis finalizing a deal for the operating rights to two oilfields in Venezuela's Orinoco Belt that hold billions of barrels of heavy oil reserves, Bloomberg saysAirbnbhas started a pilot program with some hosts, lowering its take rate from bookings to either 6% or 10%, a significant reduction from the company average of 16%, Bloomberg reportsStellantisis halting production at its Mirafiori plant in Turin due to shortages of engine components following stronger-than-expected demand for hybrid vehicles, Reuters reports4. MOVERS:Comstock Resourcesgains after announcing awith the State Oil Company of the Azerbaijan Republic and a $450M joint venture with Jerry JonesCapricor Therapeuticsincreases after Piper Sandlerthe stock to OverweightKohl'shigher after naming Ryan Waymire asAlumislower after reporting itsdid not meet its primary and secondary endpointsEos Energyfalls after filing toof stock5. EARNINGS/GUIDANCE:Nioand provided guidance for Q3MiniMed, with EPS missing consensusYext, with EPS higher year-over-yearRegis, with CEO Susan Lintonsmith commenting on "a year of continued progress toward strengthening the foundation of our business"Broadcomon September 2INDEXES:Near midday, the Dow was down 211.32, or 0.40%, to 52,974.58, the Nasdaq was down 117.74, or 0.45%, to 26,253.15, and the S&P 500 was down 24.77, or 0.32%, to 7,661.37.
Company Lowers FY26 Revenue Outlook to $863.58M
Consensus $863.58M. Sees FY26 adjusted gross margin 66%-67%. The company said, "Revised the full-year 2026 revenue range lower, reflecting Q2 results and current business trends."
Myriad Genetics Q2 Revenue $190.7M, Below Consensus
Reports Q2 revenue $190.7M, consensus $206.03M. "In the second quarter, we continued to make meaningful progress on the Cancer Care Continuum on a number of fronts, including 6% year-over-year volume growth supported by the ramp up of our expanded sales team, the launch of Prolaris + AI, the expansion of Precise MRD to include colorectal cancer and renal cancers, along with the submission of Precise MRD breast to MolDX," said Sam Raha, President and CEO, Myriad Genetics. "During the quarter, we advanced work on a strategic review with the intention to identify initiatives to increase growth, profitability, and liquidity. We have activated an initiative called Ascend to increase organizational efficiency, effectivity and scalability and are being supported by a leading professional services firm. We are also doing a rigorous evaluation of our product portfolio to determine the optimal allocation of capital and enhancement of shareholder value."
Myriad Genetics Appoints Raj Jampa as CTO
Myriad Genetics announced the appointment of Raj Jampa as chief technology officer, effective June 1. As CTO, Jampa will be responsible for strategy and execution of Myriad's technology organization, including further leveraging AI to drive increased efficiency and effectivity.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。







